These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34143187)

  • 1. Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring.
    Davis MR; Chang S; Gaynor P; McCreary EK; Allyn P
    Med Mycol; 2021 Sep; 59(9):939-942. PubMed ID: 34143187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isavuconazole in the Treatment of Coccidioidal Meningitis.
    Heidari A; Quinlan M; Benjamin DJ; Laurence B; Mu A; Ngai T; Hoffman WJ; Cohen SH; McHardy I; Johnson R; Thompson GR
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
    Naeem F; Laningham F; Kuzmic B; Clerkin P; McCarty J
    Pediatr Infect Dis J; 2021 Mar; 40(3):e128-e131. PubMed ID: 33315746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isavuconazole: Case Report and Pharmacokinetic Considerations.
    Marchesi F; Girmenia C; Goffredo BM; Salvatorelli E; Romano A; Mengarelli A; Minotti G; Menna P
    Chemotherapy; 2018; 63(5):253-256. PubMed ID: 30458443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.
    Lahmer T; Batres Baires G; Heilmaier M; Schmid RM; Sörgel F; Kinzig M; Huber W; Mayr U; Rasch S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center.
    Borman AM; Hughes JM; Oliver D; Fraser M; Sunderland J; Noel AR; Johnson EM
    Med Mycol; 2020 Oct; 58(7):996-999. PubMed ID: 32396168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
    Kovanda LL; Marty FM; Maertens J; Desai AV; Lademacher C; Engelhardt M; Lu Q; Hope WW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of coccidioidal meningitis with voriconazole.
    Cortez KJ; Walsh TJ; Bennett JE
    Clin Infect Dis; 2003 Jun; 36(12):1619-22. PubMed ID: 12802765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases.
    Kaindl T; Andes D; Engelhardt M; Saulay M; Larger P; Groll AH
    J Antimicrob Chemother; 2019 Mar; 74(3):761-767. PubMed ID: 30476108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Desai AV; Kovanda LL; Hope WW; Andes D; Mouton JW; Kowalski DL; Townsend RW; Mujais S; Bonate PL
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis.
    Heidari A; Sharma R; Shakir Q; Shah M; Clement J; Donnelley MA; Reynolds T; Trigg K; Jolliff J; Kuran R; Johnson R; Thompson GR
    Clin Infect Dis; 2023 Jun; 76(12):2196-2199. PubMed ID: 36905151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
    Tucker RM; Williams PL; Arathoon EG; Levine BE; Hartstein AI; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1988 Mar; 32(3):369-73. PubMed ID: 2835002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of
    Townsend R; Kato K; Hale C; Kowalski D; Lademacher C; Yamazaki T; Akhtar S; Desai A
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):207-216. PubMed ID: 28750160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi.
    Desai A; Kovanda L; Kowalski D; Lu Q; Townsend R; Bonate PL
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5483-91. PubMed ID: 27381396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
    Cornely OA; Böhme A; Schmitt-Hoffmann A; Ullmann AJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2078-85. PubMed ID: 25624327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole As Successful Salvage Therapy for Mucormycosis in Pediatric Patients.
    Ashkenazi-Hoffnung L; Bilavsky E; Levy I; Grisaru G; Sadot E; Ben-Ami R; Novikov A; Fischer S; Nahum E; Scheuerman O
    Pediatr Infect Dis J; 2020 Aug; 39(8):718-724. PubMed ID: 32251256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
    Wilby KJ
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):281-290. PubMed ID: 29101732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
    Sorensen KN; Sobel RA; Clemons KV; Pappagianis D; Stevens DA; Williams PL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1512-7. PubMed ID: 10817701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.